Key result
Beta-3 blockade cuts post-MI stem cell mobilization and accelerated atherosclerosis by ~50% to 100%.
Why the study?
Survivors of acute coronary syndromes have a high risk of recurrent events for unknown reasons, motivating investigation into whether the systemic response to ischaemic injury aggravates chronic atherosclerosis.
Does acute myocardial infarction or ischemic stroke accelerate pre-existing chronic atherosclerosis via sympathetic nervous system-mediated mobilization of bone marrow hematopoietic progenitors and splenic monocytopoiesis?
Does acute myocardial infarction or ischemic stroke accelerate pre-existing chronic atherosclerosis via sympathetic nervous system-mediated mobilization of bone marrow hematopoietic progenitors and splenic monocytopoiesis?
Acute ischemic injury (MI or stroke) accelerates chronic atherosclerosis by activating sympathetic signaling that liberates bone marrow progenitors to seed the spleen and sustain inflammatory monocyte production, identifying a novel therapeutic pathway to prevent recurrent cardiovascular events.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The statement doesn't hedge: the evidence, it concludes, "is no longer exploratory but is compelling and clinically actionable. The time for taking action has now arrived.”
Post-MI beta-3 blockade attenuated accelerated atherosclerosis in mice; hypothesis-generating for sympathetic-targeted therapies in secondary prevention.
During progression of atherosclerosis, myeloid cells destabilize lipid-rich plaques in the arterial wall and cause their rupture, thus triggering myocardial infarction and stroke. Survivors of acute coronary syndromes have a high risk of recurrent events for unknown reasons. Here we show that the systemic response to ischaemic injury aggravates chronic atherosclerosis. After myocardial infarction or stroke, Apoe-/- mice developed larger atherosclerotic lesions with a more advanced morphology. This disease acceleration persisted over many weeks and was associated with markedly increased monocyte recruitment. Seeking the source of surplus monocytes in plaques, we found that myocardial infarction liberated haematopoietic stem and progenitor cells from bone marrow niches via sympathetic nervous system signalling. The progenitors then seeded the spleen, yielding a sustained boost in monocyte production. These observations provide new mechanistic insight into atherogenesis and provide a novel therapeutic opportunity to mitigate disease progression.
No takes yet. Share an insight, caveat, or question.
Dutta et al. (2012) studied Atherosclerosis and acute myocardial infarction or ischemic stroke. Experimental myocardial infarction (coronary ligation), ischemic stroke, and beta-3 adrenergic receptor antagonist treatment vs. Mice without myocardial infarction or without beta-3 adrenergic blocker treatment was evaluated on Atherosclerotic plaque size, protease activity, and myeloid cell/monocyte recruitment along with HSPC mobilization from bone marrow to spleen. Myocardial infarction increased circulating hematopoietic stem and progenitor cells 24-fold at 96 hours and accelerated atherosclerosis in Apoe-/- mice, which beta-3 blockade reduced by 50-100%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: